Related Experiment Video
Updated: Jul 23, 2026

08:05
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
1.1K
Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA
Rashad Ismayilov1, Ayse Aktas2, Esra Arzu Gencoglu2
1Department of Medical Oncology, Baskent University, Faculty of Medicine, Ankara, Türkiye. ismayilov_r@hotmail.com.
Molecular Imaging and Biology
|December 5, 2025
Summary
Large language models (LLMs) accurately stage prostate cancer from PSMA PET-CT reports. This technology aids data automation and research acceleration in oncology.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Oncology
Background:
- Accurate prostate cancer staging is crucial for treatment decisions.
- Unstructured PSMA PET-CT reports limit large-scale data analysis.
- Large language models (LLMs) show potential for extracting structured data from clinical reports.
Purpose of the Study:
- To assess the feasibility of using LLMs for multi-step clinical reasoning in prostate cancer staging.
- To evaluate the performance of Gemini 2.5 Pro and ChatGPT 4o in staging prostate cancer from PSMA PET-CT reports.
Main Methods:
- 80 Turkish PSMA PET-CT reports were analyzed by Gemini 2.5 Pro and ChatGPT 4o.
- LLMs used structured prompts with embedded knowledge (AJCC/CHAARTED criteria) and few-shot examples.
- Classifications for T, N, M stages, and disease volume were benchmarked against expert staging.
Main Results:
- Gemini 2.5 Pro achieved 93.8% accuracy and 0.910 kappa for composite staging.
- ChatGPT 4o achieved 91.3% accuracy and 0.874 kappa for composite staging.
- Both LLMs exceeded 95% accuracy for N and M staging, demonstrating near-perfect agreement.
Conclusions:
- Expert-guided LLMs can accurately stage prostate cancer from free-text PSMA PET-CT reports.
- LLMs show promise as assistive tools for automating data extraction and accelerating research.
- This approach can enhance quality assurance in oncological data management.

